288 related articles for article (PubMed ID: 38396977)
21. A Young Male with Parafibromin-Deficient Parathyroid Carcinoma Due to a Rare Germline HRPT2/CDC73 Mutation.
Kapur A; Singh N; Mete O; Hegele RA; Fantus IG
Endocr Pathol; 2018 Dec; 29(4):374-379. PubMed ID: 30361844
[TBL] [Abstract][Full Text] [Related]
22. [CDC73 mutations in young patients with primary hyperparathyroidism: A description of two clinical cases].
Mamedova EO; Mokrysheva NG; Pigarova EA; Przhiyalkovskaya EG; Voronkova IA; Vasilyev EV; Petrov VM; Gorbunova VA; Rozhinskaya LY; Belaya ZE; Tyulpakov AN
Ter Arkh; 2016; 88(10):57-62. PubMed ID: 27801421
[TBL] [Abstract][Full Text] [Related]
23. A large extended family with hyperparathyroidism-jaw tumor syndrome due to deletion of the third exon of CDC73: clinical and molecular features.
Le Collen L; Barraud S; Braconnier A; Coppin L; Zachar D; Boulagnon C; Deguelte S; Souchon PF; Spodenkiewicz M; Poirsier C; Aubert S; Odou MF; Delemer B
Endocrine; 2021 Sep; 73(3):693-701. PubMed ID: 33999366
[TBL] [Abstract][Full Text] [Related]
24. Parafibromin Abnormalities in Ossifying Fibroma.
Costa-Guda J; Pandya C; Strahl M; Taik P; Sebra R; Chen R; Uzilov AV; Arnold A
J Endocr Soc; 2021 Jul; 5(7):bvab087. PubMed ID: 34159287
[TBL] [Abstract][Full Text] [Related]
25. Hyperparathyroidism-jaw Tumor Syndrome Confirmed by Preoperative Genetic Testing.
Koikawa K; Okada Y; Mori H; Kawaguchi M; Uchino S; Tanaka Y
Intern Med; 2018 Mar; 57(6):841-844. PubMed ID: 29225260
[TBL] [Abstract][Full Text] [Related]
26. Rare duplication of the CDC73 gene and atypical hyperparathyroidism-jaw tumor syndrome: A case report and review of the literature.
Garrigues G; Batisse-Lignier M; Uhrhammer N; Privat M; Ponelle-Chachuat F; Kelly A; Gay-Bellile M; Viala S; Bidet Y; Bignon YJ; Cavaillé M
Mol Genet Genomic Med; 2023 May; 11(5):e2133. PubMed ID: 36639964
[TBL] [Abstract][Full Text] [Related]
27. Hyperparathyroidism-jaw tumor syndrome: Results of operative management.
Mehta A; Patel D; Rosenberg A; Boufraqech M; Ellis RJ; Nilubol N; Quezado MM; Marx SJ; Simonds WF; Kebebew E
Surgery; 2014 Dec; 156(6):1315-24; discussion 1324-5. PubMed ID: 25444225
[TBL] [Abstract][Full Text] [Related]
28. Genotype of CDC73 germline mutation determines risk of parathyroid cancer.
Li Y; Zhang J; Adikaram PR; Welch J; Guan B; Weinstein LS; Chen H; Simonds WF
Endocr Relat Cancer; 2020 Sep; 27(9):483-494. PubMed ID: 32590342
[TBL] [Abstract][Full Text] [Related]
29. Hyperparathyroidism-jaw tumor syndrome: a report of three large kindred.
Iacobone M; Masi G; Barzon L; Porzionato A; Macchi V; Ciarleglio FA; Palù G; De Caro R; Viel G; Favia G
Langenbecks Arch Surg; 2009 Sep; 394(5):817-25. PubMed ID: 19529956
[TBL] [Abstract][Full Text] [Related]
30. Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome.
Bradley KJ; Hobbs MR; Buley ID; Carpten JD; Cavaco BM; Fares JE; Laidler P; Manek S; Robbins CM; Salti IS; Thompson NW; Jackson CE; Thakker RV
J Intern Med; 2005 Jan; 257(1):18-26. PubMed ID: 15606373
[TBL] [Abstract][Full Text] [Related]
31. Phenotype of Parathyroid-targeted
Costa-Guda J; Cohen ST; Romano R; Acostamadiedo J; Clark K; Bellizzi J; Arnold A
J Endocr Soc; 2024 Jan; 8(3):bvae006. PubMed ID: 38328479
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide and locus specific alterations in CDC73/HRPT2-mutated parathyroid tumors.
Sulaiman L; Haglund F; Hashemi J; Obara T; Nordenström J; Larsson C; Juhlin CC
PLoS One; 2012; 7(9):e46325. PubMed ID: 23029479
[TBL] [Abstract][Full Text] [Related]
33. Crystal structure of the N-terminal domain of human CDC73 and its implications for the hyperparathyroidism-jaw tumor (HPT-JT) syndrome.
Sun W; Kuang XL; Liu YP; Tian LF; Yan XX; Xu W
Sci Rep; 2017 Nov; 7(1):15638. PubMed ID: 29142233
[TBL] [Abstract][Full Text] [Related]
34. Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism.
Masi G; Barzon L; Iacobone M; Viel G; Porzionato A; Macchi V; De Caro R; Favia G; Palù G
Endocr Relat Cancer; 2008 Dec; 15(4):1115-26. PubMed ID: 18755853
[TBL] [Abstract][Full Text] [Related]
35. CDC73-related hereditary hyperparathyroidism: five new mutations and the clinical spectrum.
Frank-Raue K; Haag C; Schulze E; Keuser R; Raue F; Dralle H; Lorenz K
Eur J Endocrinol; 2011 Sep; 165(3):477-83. PubMed ID: 21652691
[TBL] [Abstract][Full Text] [Related]
36. Parafibromin expression, single-gland involvement, and limited parathyroidectomy in familial isolated hyperparathyroidism.
Iacobone M; Barzon L; Porzionato A; Masi G; Macchi V; Marino F; Viel G; Favia G
Surgery; 2007 Dec; 142(6):984-91; discussion 984-91. PubMed ID: 18063086
[TBL] [Abstract][Full Text] [Related]
37. HRPT2- (CDC73) RELATED HEREDITARY HYPERPARATHYROIDISM: A CASE SERIES FROM WESTERN INDIA.
Khadilkar KS; Budyal SR; Kasliwal R; Lila AR; Bandgar T; Shah NS
Endocr Pract; 2015 Sep; 21(9):1010-6. PubMed ID: 26121439
[TBL] [Abstract][Full Text] [Related]
38. Novel HRPT2/CDC73 gene mutations and loss of expression of parafibromin in Chinese patients with clinically sporadic parathyroid carcinomas.
Wang O; Wang C; Nie M; Cui Q; Guan H; Jiang Y; Li M; Xia W; Meng X; Xing X
PLoS One; 2012; 7(9):e45567. PubMed ID: 23029104
[TBL] [Abstract][Full Text] [Related]
39. CDC73-Related Disorders: Clinical Manifestations and Case Detection in Primary Hyperparathyroidism.
van der Tuin K; Tops CMJ; Adank MA; Cobben JM; Hamdy NAT; Jongmans MC; Menko FH; van Nesselrooij BPM; Netea-Maier RT; Oosterwijk JC; Valk GD; Wolffenbuttel BHR; Hes FJ; Morreau H
J Clin Endocrinol Metab; 2017 Dec; 102(12):4534-4540. PubMed ID: 29040582
[TBL] [Abstract][Full Text] [Related]
40. CDC73 gene mutations in sporadic ossifying fibroma of the jaws.
Chen Y; Hu DY; Wang TT; Zhang R; Dong Q; Xu ZX; Wang L; Li TJ
Diagn Pathol; 2016 Sep; 11(1):91. PubMed ID: 27658992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
